norgestrel (Compound)

Synonyms:Levonorgestrel, norgestrel, 797-63-7, D-Norgestrel, Mirena, (-)-Norgestrel, Levonova, Microval, Postinor, Plan B, NORPLANT, Jadelle, dl-Norgestrel, Follistrel, 18-Methylnorethisterone, Levonorgestrelum, Ovrette, 6533-00-2, d(-)-Norgestrel, Levonelle, Neogest, Levonorgestrelum [INN-Latin], Liletta, Fallback Solo, Monovar, Wy-5104, Norgestrel-(-)-D, 17-Ethynyl-18-methyl-19-nortestosterone, 17alpha-Ethynyl-18-homo-19-nortestosterone, 18-Methyl-17-alpha-ethynyl-19-nortestosterone, 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one, 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one, Norgestrelum, 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol, 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one, BAY86-5028, Norgestrel, (-)-, Norgestrel (-)-form, Norplant 2, Microlution, Ovranette, Triagynon, Triciclor, Microgyn, Microlut, 5W7SIA7YZW, Nordet, Trigoa, Wy 3707, Wy-3707, 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one, NSC-744007, Microgynon CD, Microgest ED, Norplant II, (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, Logynon ED, Ovral-Lo, Levlen ED, Microgynon 21, Microgynon 28, Trinordiol 21, Trinordiol 28, MLS000069491, CHEBI:6443, Minivlar 30, Monofeme 28, Neogynon 21, Nordette 21, Nordette 28, Stediril 30, Trifeme 28, DTXSID3036496, DTXSID3047477, Preven, Levora-21, Levora-28, Microgynon 30 ED, Tri-Levlen 21, 17-alpha-Ethynyl-13-ethyl-19-nortestosterone, Rigevidon 21+7, FH 122-A, NorLevo, 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, SH 850, Triquilar ED, LD norgestrel [French], Triphasil 21, Triphasil 28, 3J8Q1747Z2, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one, SH 70850, NCGC00159349-02, Norgestrelum [INN-Latin], 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, SMR000059117, Levonorgestrel implants, E-Gen-C, Norgestrel [Progestins], Ovoplex 30-150, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, DTXCID1016496, Microluton, Levogel, Levosert, Skyla, 13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one, Next choice, Norplant System in Plastic Container, Plan B One Step, Plan B One-Step, Norplant (TN), rel-(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, Ovrette (TN), Mirena (TN), CCRIS 6525, CCRIS 9033, Levonorgestrel (Levonelle), HSDB 3595, HSDB 6483, LNG-IUS, 17alpha-Ethynyl-13-ethyl-19-nortestosterone, 13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, EINECS 212-349-8, EINECS 229-433-5, UNII-5W7SIA7YZW, BRN 2391114, FH-122A, 13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one, Kyleena, dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone, SH-850, 19-Nortestosterone, 17-ethynyl-18-methyl-, Levonorgestrel (JAN/USP/INN), UNII-3J8Q1747Z2, 1lhv, NSC-757251, Oral levonorgestrel, CAS-797-63-7, LNG, SH-70850, Prestwick_109, (+-)-Norgestrel, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-, (-)-Levonorgestrel, Levonorgestrel [USAN:USP:INN:BAN], MFCD00199013, Levonorgestrel implant, Skyla (TN), Norgestrel [USAN:USP:INN:BAN:JAN], BAY 86-5028, NORGESTREL [MI], Opera_ID_552, Levonorgestrel(Levonelle), NORGESTREL [INN], NORGESTREL [JAN], dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one, Prestwick0_000773, Prestwick1_000773, Prestwick2_000773, Prestwick3_000773, NORGESTREL [HSDB], NORGESTREL [USAN], Intrauterine levonorgestrel, 17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one, NORGESTREL [VANDF], (+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, (-)-Norgestrel, 98%, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-, NORGESTREL [MART.], CHEMBL1389, LEVONORGESTREL [INN], LEVONORGESTREL [JAN], NORGESTREL [USP-RS], NORGESTREL [WHO-DD], BIDD:PXR0194, SCHEMBL27597, BSPBio_000846, LEVONORGESTREL [HSDB], LEVONORGESTREL [USAN], MLS000759484, MLS001074069, MLS001423967, LEVONORGESTREL [VANDF], SPBio_002785, LEVONORGESTREL [MART.], 13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one, BPBio1_000932, GTPL2881, Norgestrel (JP17/USP/INN), LEVONORGESTREL [USP-RS], LEVONORGESTREL [WHO-DD], LEVONORGESTREL [WHO-IP], NORGESTREL [ORANGE BOOK], OVRAL COMPONENT NORGESTREL, 17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one, NORGESTREL [EP MONOGRAPH], IMPLANT WITH LEVONORGESTREL, DTXCID401079284, HMS1570K08, HMS2051M08, HMS2090O06, HMS2097K08, HMS2232H06, HMS2232K12, HMS3649J10, HMS3714K08, HMS3886K18, NORGESTREL [USP MONOGRAPH], AMY40476, CRYSELLE COMPONENT NORGESTREL, HY-B0257, NORGESTREL (-)-FORM [MI], D-(-)-Norgestrel (Levonorgestrel), LEVONORGESTREL [ORANGE BOOK], NORGESTREL COMPONENT OF OVRAL, Tox21_111593, Tox21_202872, Tox21_303623, Tox21_303658, BDBM50410522, LEVONORGESTREL [EP MONOGRAPH], LEVONORGESTREL [USP IMPURITY], LMST02030119, NSC744007, s1727, s5709, ALESSE COMPONENT LEVONORGESTREL, AVIANE COMPONENT LEVONORGESTREL, D(-)-Norgestrel, analytical standard, LEVONORGESTREL [USP MONOGRAPH], LEVORA COMPONENT LEVONORGESTREL, LYBREL COMPONENT LEVONORGESTREL, PORTIA COMPONENT LEVONORGESTREL, PREVEN COMPONENT LEVONORGESTREL, TWIRLA COMPONENT LEVONORGESTREL, VIENVA COMPONENT LEVONORGESTREL, 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, AKOS015894913, KURVELO COMPONENT LEVONORGESTREL, KYLEENA COMPONENT LEVONORGESTREL, LESSINA COMPONENT LEVONORGESTREL, LEVLITE COMPONENT LEVONORGESTREL, MYZILRA COMPONENT LEVONORGESTREL, PLASTIC IUD WITH LEVONORGESTREL, Tox21_111593_1, TRIVORA COMPONENT LEVONORGESTREL, BCP9000852, CCG-100853, DB00367, Levonorgestrel for system suitability 1, Levonorgestrel for system suitability 2, LEVONORGESTRELUM [WHO-IP LATIN], NC00103, NORGESTREL COMPONENT OF CRYSELLE, NSC 744007, NSC 757251, NSC 759653, 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-, ALTAVERA COMPONENT LEVONORGESTREL, ELIFEMME COMPONENT LEVONORGESTREL, ENPRESSE COMPONENT LEVONORGESTREL, LEVONEST COMPONENT LEVONORGESTREL, MARLISSA COMPONENT LEVONORGESTREL, NORDETTE COMPONENT LEVONORGESTREL, ORSYTHIA COMPONENT LEVONORGESTREL, QUASENSE COMPONENT LEVONORGESTREL, SETLAKIN COMPONENT LEVONORGESTREL, [18,(17.alpha.)-(-)-], AFIRMELLE COMPONENT LEVONORGESTREL, INTROVALE COMPONENT LEVONORGESTREL, LEVONORGESTREL COMPONENT OF ALESSE, LEVONORGESTREL COMPONENT OF LYBREL, LEVONORGESTREL COMPONENT OF PREVEN, LEVONORGESTREL COMPONENT OF TWIRLA, NCGC00159349-03, NCGC00159349-05, NCGC00256735-01, NCGC00257283-01, NCGC00260418-01, QUARTETTE COMPONENT LEVONORGESTREL, SEASONALE COMPONENT LEVONORGESTREL, TRIPHASIL COMPONENT LEVONORGESTREL, LEVONORGESTREL COMPONENT OF KYLEENA, LEVONORGESTREL COMPONENT OF LEVLITE, SEASONIQUE COMPONENT LEVONORGESTREL, SMR000653526, CAS-6533-00-2, CLIMARA PRO COMPONENT LEVONORGESTREL, LEVONORGESTREL COMPONENT OF ALTAVERA, LEVONORGESTREL COMPONENT OF LEVONEST, LEVONORGESTREL COMPONENT OF QUASENSE, LEVONORGESTREL COMPONENT OF SETLAKIN, LEVONORGESTREL COMPONENT OF INTROVALE, LEVONORGESTREL COMPONENT OF SEASONALE, LOSEASONIQUE COMPONENT LEVONORGESTREL, LEVONORGESTREL COMPONENT OF SEASONIQUE, N0889, NORGESTIMATE IMPURITY B [EP IMPURITY], Levonorgestrel 100 microg/mL in Acetonitrile, LEVONORGESTREL COMPONENT OF CLIMARA PRO, C08149, C08153, D00950, D00954, EN300-122613, L-4455, LEVONORGESTREL COMPONENT OF LOSEASONIQUE, OPCICON ONE-STEP COMPONENT LEVONORGESTREL, Q416950, SR-01000759218, SR-01000946725, (-)-17alpha-Ethynyl-18-methyl-19-nortestosterone, LEVONORGESTREL COMPONENT OF OPCICON ONE-STEP, SR-01000759218-5, SR-01000946725-1, BRD-K35189033-001-03-0, 13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, Z1544404028, 13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one, (17?)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-yn-3-one, 13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one, Levonorgestrel, British Pharmacopoeia (BP) Reference Standard, Levonorgestrel, European Pharmacopoeia (EP) Reference Standard, Levonorgestrel, United States Pharmacopeia (USP) Reference Standard, (-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one, [(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one, (+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, (-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, [18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-,(17..)-(-)-], 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(+/-)-, 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(-)-, Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard, Levonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material, (1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one

Pubchem:PUBCHEM:29985980

Id:46c237a6-2bfc-56bc-8876-d667702e9f94